• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

水化对行经皮冠状动脉介入治疗患者发生主要不良心脑血管事件及肾损伤的影响

The effect of hydration on the main adverse cardiovascular and cerebrovascular events and kidney injury in patients undergoing percutaneous coronary intervention

摘要:

目的 评估水化治疗对应用碘克沙醇作为对比剂的行经皮冠状动脉介入治疗( PCI)患者预后的影响.方法 选取2013年10月至2015年10月来自中国30 个中心的行PCI治疗的3 042例冠状动脉粥样硬化性心脏病患者,对所有患者进行术后72 h的观察及出院后30 d的随访.根据患者术前是否进行水化治疗,分为水化组和非水化组.水化组846例,男617例,女229例;非水化组2 196例,男1 596例,女600例.本研究主要终点事件为PCI术后72 h内不良心脑血管事件(MACCE).其中MACCE定义为:靶病变再次血运重建、卒中、支架内血栓形成、心源性死亡、心肌梗死.次要终点为术后至30 d内的MACCE的发生率及对比剂诱导急性肾损伤(CI-AKI)的发生率.结果 (1)两组患者的基线资料比较:水化组与非水化组在年龄[(61.91 ± 10.61)岁、(63.43 ± 10.93)岁,P<0.001)]、体质量指数[(25.19 ± 3.17) kg/m2、(24.37 ± 3.11) kg/m2 ,P<0.001)]、疾病史/手术史[91.84% (777/846 )、 84.15% ( 1 848/2 196 ), P < 0.001 )]、高脂血症[ 70.09% (593/846)、53.32% (1 171/2 196),P<0.001]、糖尿病[28.96% (245/846)、23.27% (511/2 196), P=0.001]、应用β受体阻滞剂[38.77% (328/846)、44.99% (988/2 196),P=0.002]、服用降糖药[21.63% (183/846)、16.80% (369/2 196),P=0.002]、阻塞性冠状动脉疾病类型( P<0.001)等方面比较,差异有统计学意义. ( 2 )围术期及用药情况:水化组与非水化组患者 PCI 水化容量[(641.55 ± 358.52)ml、(813.20 ± 472.17) ml,P <0.001]、水化总容量[(1 113.60 ± 653.08) ml、(813.20 ± 472.17)ml,P<0.001]等比较,差异有显著统计学意义.两组患者术中使用碘克沙醇容量[(153.29 ± 59.69 ) ml、 (135.48 ± 56.42 ) ml, P < 0.001 ]、利尿剂[ 1.18% ( 10/846 )、 3.42% (75/2 196),P<0.001]、β受体阻滞剂[14.89% (126/846)、20.63% (453/2 196),P<0.001]、其他药物[62.17% (526/846)、56.47% (1 240/2 196),P=0.004]比较,差异有统计学意义. (3)主要终点:术后72 h内发生MACCE,水化组患者27例(3.19% ),非水化组44例(2.00% )发生MACCE,其中水化组心肌梗死27例(3.19% ),非水化组心源性死亡1例(0.05% ),心肌梗死43例(1.96% ),差异均无统计学意义.次要终点:行PCI后72 h后至30 d发生MACCE,水化组1例(0.12% ),非水化组5例(0.24% ),其中水化组心肌梗死1例(0.12% ),非水化组靶血管血运重建1例(0.05% ),支架内血栓形成1例(0.05% )、心源性死亡3例(0.14% ),差异均无统计学意义. PCI术后72 h内两组患者CI-AKI的发生率比较[7.09% (58/846)、8.15% (175/2 196)],差异无统计学意义(P=0.339).结论 等渗对比剂碘克沙醇在中国PCI人群中安全性再次得到证明,水化治疗对于患者预后无不良影响.

更多
abstracts:

Objective To evaluate the prognosis of hydration therapy on patients undergoing per-cutaneous coronary intervention(PCI) with iodixanol. Methods A retrospective study was performed on 3 042 cases of patients who were admitted from October 2013 to October 2015. All the patients were per-formed observation 72 hours after operation and 30 days after discharge. According to whether the patients received hydration treatment before surgery,they were divided into the hydration group and the non-hydra-tion group. There were 846 cases in the hydration therapy group,including 617 male cases and 229 female cases. There were 2 196 cases in the non-hydrated therapy group,including 1 596 male cases and 600 fe-male cases. The main endpoint event of this study was major adverse cerebrovascular events(MACCE)with-in 72 hours after PCI.MACCE was defined as target lesion revascularization,stroke,stent thrombosis,cardi-ac death,and myocardial infarction. The secondary endpoint was the incidence of MACCE and the incidence of contrast induced acute kidney injury(CI-AKI) within 30 days after surgery. Results (1) Baseline data of The two groups:there were significant differences between hydration therapy group and non-hydrated ther-apy group in age[(61.91 ± 10.61) years old,(63.43 ± 10.93) years old,P<0.001)],BMI [(25.19 ± 3.17) kg/m2 , (24.37 ± 3.11) kg/m2 , P <0.001 )], history of disease/surgery [ 91.84% ( 777/846 )、84.15% (1 848/2 196),P<0.001)],hyperlipemia[70.09% (593/846)、53.32% (1 171/2 196),P<0.001],diabetes mellitus[28.96% (245/846)、23.27% (511/2 196),P=0.001],β-blocker[38.77% (328/846)、44.99% (988/2 196),P=0.002],hypoglycemic agents[21.63% (183/846)、16.80% (369/2 196),P=0.002] and the obstruction of coronary artery disease(P<0.001). (2) Perioperative period and medication:PCI hydration capacity[(641.55 ± 358.52) ml,(813.20 ± 472.17)ml,P<0.001],and total hydration capacity[(1 113.60 ± 653.08)ml,(813.20 ± 472.17) ml,P<0.001] were differ between the groups.Significant differences were observed in: the dosage of iodixanol [( 153.29 ± 59.69 ) ml, (135.48 ± 56.42)ml,P<0.001],diuretic[1.18% (10/846)、3.42% (75/2 196),P<0.001],β-bloc-ker [ 14.89% ( 126/846 )、20.63% ( 453/2 196 ), P <0.001 ], and other drugs [ 62.17% (526/846 )、56.47% (1 240/2 196),P =0.004] between the two groups during intraoperation. (3) Main endpoint:MACCE occurred within 72 hours after surgery in 27 ( 3.19% ) patients in the hydration group and 44(2.00% )patients in the non-hydration group,including 27(3.19% ) patients in the hydration group, 1(0.05% )patients in the non-hydration group and 43(1.96% )patients in the myocardial infarction group. The difference was not statistically significant ( P >0.05).Secondary end points:72 hours after PCI to 30 days after MACCE,hydration group 1 case(0.12% ),the hydration group 5 cases(0.24% ),the hydra-tion group of myocardial infarction,1 case(0.12% ),1 case of nonhydratable group target essel revascular-ization(0.05% ),stent thrombosis in 1 case(0.05% ),3 cases(0.14% ),cardiac death differences had no statistical significance. The incidence of CI-AKI in the two groups within 72 hours after PCI was compared [7.09% (58/846)、8.15% (175/2 196)],and the difference was not statistically significant(P=0.339). Conclusion The safety of isosmotic contrast agent iodixanol is demonstrated again in Chinese PCI popula-tion and no adverse effect is observed of hydration therapy on patient prognosis.

More
作者: 赵莹莹 [1] 鲍丹 [1] 王效增 [1] 韩雅玲 [1] 周铁楠 [1] 顾若曦 [1] 张权宇 [1]
栏目名称: 论著
DOI: 10.3760/cma.j.issn.1673-8799.2019.03.001
发布时间: 2019-07-25
基金项目:
国家十三五重点研发计划项目 国家十三五重点研发计划课题(2016YFC1301303) Fund program:National 13th Five-Year Plan Key R&D Projects National Key Research and Development Projects for the 13th Five-Year Plan
  • 浏览:103
  • 下载:116

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷